Alpine Woods Capital Investors LLC Has $5.72 Million Holdings in Intuitive Surgical, Inc. $ISRG

Alpine Woods Capital Investors LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% during the second quarter, Holdings Channel.com reports. The firm owned 10,519 shares of the medical equipment provider’s stock after selling 331 shares during the quarter. Intuitive Surgical makes up 1.4% of Alpine Woods Capital Investors LLC’s investment portfolio, making the stock its 21st biggest holding. Alpine Woods Capital Investors LLC’s holdings in Intuitive Surgical were worth $5,716,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Chilton Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical during the first quarter worth $26,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical during the first quarter worth $30,000. TD Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.4%

ISRG opened at $435.73 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company has a market cap of $156.20 billion, a P/E ratio of 60.77, a price-to-earnings-growth ratio of 4.51 and a beta of 1.61. The company has a fifty day moving average price of $457.73 and a two-hundred day moving average price of $497.44.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the firm posted $1.78 earnings per share. The business’s revenue was up 21.4% compared to the same quarter last year. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ISRG. Truist Financial lifted their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Evercore ISI lowered their target price on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research note on Tuesday, October 7th. BTIG Research lowered their target price on shares of Intuitive Surgical from $571.00 to $529.00 and set a “buy” rating for the company in a research note on Monday. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Wednesday, October 8th. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $584.76.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 45,224 shares of company stock valued at $21,716,492. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.